Hearing News Watch

Featured image for “CHS Global Partnerships for Research & Innovation Awards Four Research Grants to Advance Hearing Health and Deaf Studies”
Jan. 10, 2023

CHS Global Partnerships for Research & Innovation Awards Four Research Grants to Advance Hearing Health and Deaf Studies

HHTM
TORONTO, CANADA – CHS Global Partnerships for Research & Innovation, a non-profit  organization and strategic global leader in the advancement of research and innovation that  improves the quality of life for Deaf and hard of hearing individuals, is excited to announce that it  has awarded its first four research grants – totaling $400,000 – to institutions leading research that “will
Featured image for “EUHA Announces New Guideline Implanted Hearing Systems”
Jan. 06, 2023

EUHA Announces New Guideline Implanted Hearing Systems

HHTM
After several months of intensive collaboration, the EUHA “Hearing Implants” expert group has published a new Guideline for “Implanted hearing systems in auditory acoustics”. It serves as a practical recommendation for hearing aid acousticians. People with hearing loss have many options to improve their hearing benefiting from the latest technology. For most of those affected, a hearing system fitted to
Featured image for “Sensorion Announces First Patient Enrolled in Phase 2a Clinical Trial of SENS-401 in Patients Suffering from Cisplatin-Induced Ototoxicity”
Jan. 03, 2023

Sensorion Announces First Patient Enrolled in Phase 2a Clinical Trial of SENS-401 in Patients Suffering from Cisplatin-Induced Ototoxicity

HHTM
MONTPELLIER, FRANCE — Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces that the first patient has been enrolled in its Phase 2a Proof of Concept clinical trial of SENS-401 (Arazasetron) in patients suffering from Cisplatin-Induced Ototoxicity. Cisplatin and
Featured image for “Passages 2022: Dr. Susan Small and Dr. David Baguley”
Dec. 31, 2022

Passages 2022: Dr. Susan Small and Dr. David Baguley

HHTM
The profession of audiology was born during World War II, and the first generation of formally educated audiologists graduated in the late 1940s. The ranks of baby boomer audiologists … born during those years and now septuagenarians are thinning due to retirement or death. Sadly, in 2022 we lost two prominent audiologists who were by any measure in the prime
Featured image for “Top Hearing News and Technology Stories of 2022”
Dec. 29, 2022

Top Hearing News and Technology Stories of 2022

HHTM
Like last year, in spite of a global pandemic, the hearing care space continued to innovate and evolve in 2022. Legislative changes, industry developments and disruptive technologies were among this year’s list of ‘most read’ hearing news and technology stories. Top Stories of 2022   1) FDA Issues Final OTC Hearing Aid Rule and PSAP Guidance In what comes as
Featured image for “Researchers Find Checkerboard-Like Arrangement of Cells in Inner Ear Vital for Hearing”
Dec. 27, 2022

Researchers Find Checkerboard-Like Arrangement of Cells in Inner Ear Vital for Hearing

HHTM
KOBE, JAPAN — A Japanese research group has become the first to reveal that the checkerboard-like arrangement of cells in the inner ear’s organ of Corti is vital for hearing. The discovery gives a new insight into how hearing works from the perspective of cell self-organization and will also enable various hearing loss disorders to be better understood. The research
Featured image for “Amptify Appoints Chris Cardinal as Chief Executive Officer”
Dec. 27, 2022

Amptify Appoints Chris Cardinal as Chief Executive Officer

HHTM
ST. LOUIS, MISSOURI — Amptify has announced that Chris Cardinal, President and Chief Operating Officer of Amptify, has been appointed Chief Executive Officer, effective immediately, succeeding Nancy Tye-Murray, PhD. Dr. Tye-Murray remains in her position as Chair of the Board and assumes the position of Chief Scientific Officer. Cardinal joined Amptify as President and COO in early 2019 on the
Featured image for “Difficulty Hearing in Background Noise Among Older Adults May Be Result of too Many Brain Cells Firing at Once, Say Researchers”
Dec. 23, 2022

Difficulty Hearing in Background Noise Among Older Adults May Be Result of too Many Brain Cells Firing at Once, Say Researchers

HHTM
BALTIMORE, MARYLAND — Looking for answers about how the brain works amid age-related hearing loss, Johns Hopkins Medicine researchers say they found that old mice were less capable than young mice of “turning off” certain actively firing brain cells in the midst of ambient noise. The result, they say, creates a “fuzzy” sound stage that makes it difficult for the
Featured image for “With New $1M Grant, Bionics Institute’s Novel Hearing Diagnostic System, EarGenie, Moves Towards Commercialization”
Dec. 22, 2022

With New $1M Grant, Bionics Institute’s Novel Hearing Diagnostic System, EarGenie, Moves Towards Commercialization

HHTM
MELBOURNE, AUSTRALIA — The Bionics Institute’s development of a ground-breaking hearing test for babies, called EarGenie ®, is one of 16 projects to be funded by the latest National Health and Medical Research Council (NHMRC) Development Grant round in December 2022. The awarded grant budget of $1,176,999.50 (~$788K USD) is the second highest amount given to any research project in the latest
Featured image for “New Study Finds Wrist Worn Device Provides Clinically Significant Reduction in Tinnitus Symptoms”
Dec. 21, 2022

New Study Finds Wrist Worn Device Provides Clinically Significant Reduction in Tinnitus Symptoms

HHTM
PALO ALTO, CALIFORNIA — Neosensory, a technology company designing breakthrough solutions for hearing loss, has published new results in their recent scientific study of Duo, their therapeutic intervention for tinnitus. The group of participants who used Neosensory’s Duo solution daily for eight weeks reported clinically significant reduction in their tinnitus severity. The paper is available online: Bimodal stimulation for the